Quang X. Pham, Chairman, CEO and Interim CFO, 10% Owner at Cadrenal Therapeutics, Inc. (CVKD), sold 11,156 shares at $3.00 ($34K) on 2026-06-25, disclosed to the SEC on 2026-06-26.
Scheduled sale ($34k) by Chairman, CEO and Interim CFO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.00 | 2,127 | $6K | 18.8% |
| 2 | $3.05 | 9,029 | $28K | 81.2% |
| Total | $3.04 avg | 11,156 | $34K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |
| CVKD | SELL | 2026-06-10 | $93K | — | Filing → |